Basic HTML Version
103
MEMÒRIA CIENTÍFICA 2012
in routine clinical practice
. Vallecillo G, Domingo P, Mallolas J, Blanch J, Ferrer E,
Cervantes M, Pedrol E, Knobel H, Llibre JM.
AIDS Res Hum Retroviruses
. 2012 Sep;28(9):1000-6.
Definition of advanced age in HIV
infection: looking for an age cut-off
. Blanco JR, Jarrín I, Vallejo M, Berenguer J, Solera C,
Rubio R, Pulido F, Asensi V, del Amo J, Moreno S; CoRIS (Segura F, Amengual MJ, Penelo E,
Navarro G, Sala M, Cervantes M, Pineda V.).
AIDS Res Treat
. 2012;2012:725412.
Imputation of the Date of HIV Seroconversion in a
Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis
.
Sobrino-Vegas P, Pérez-Hoyos S, Geskus R, Padilla B, Segura F, Rubio R, Del Romero J,
Santos J, Moreno S, Del Amo J, CoRIS (Navarro G.).
AIDS
. 2012 Aug 24;26(13):1691-705.
The effect of efavirenz versus nevirapine-containing
regimens on immunologic, virologic and clinical outcomes in a prospective
observational study
. HIV-CAUSAL Collaboration (Segura F, Amengual MJ, Penelo E, Navarro
G, Sala M, Cervantes M, Bejarano G.).
AIDS
. 2012 Nov 13;26(17):2241-6.
Trends in mortality according to hepatitis C virus
serostatus in the era of combination antiretroviral therapy
. Berenguer J, Alejos B,
Hernando V, Viciana P, Salavert M, Santos I, Gómez-Sirvent JL, Vidal F, Portilla J, Del Amo J;
CoRIS (AIDS Research Network Cohort) (Segura F, Navarro G.).
AIDS
. 2012 Sep 10;26(14):1829-34.
Differences in the causes of death of HIV-positive
patients in a cohort study by data sources and coding algorithms
. Hernando V, Sobrino-
Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, Reparaz J, Martínez MA, Antela A,
Gutiérrez F, del Amo J; CoRIS cohort (Segura F, Amengual MJ, Penelo E, Navarro G, Sala M,
Cervantes M, Pineda V. ).
Aliment Pharmacol Ther
. 2012 Apr;35(8):941-7.
Fourth-line rescue therapy with rifabutin in
patients with three Helicobacter pylori eradication failures
. Gisbert JP, Castro-Fernandez
M, Perez-Aisa A, Cosme A, Molina-Infante J, Rodrigo L, Modolell I, Cabriada JL, Gisbert JL,
Lamas E, Marcos E, Calvet X.
Aliment Pharmacol Ther
. 2012 Jan;35(2):209-21.
Review article: rifabutin in the treatment of
refractory Helicobacter pylori infection
. Gisbert JP, Calvet X.
Aliment Pharmacol Ther
. 2012 Jul;36(2):190-6.
High-dose, ten-day esomeprazole,
amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori
eradication rates
. Sánchez-Delgado J, García-Iglesias P, Castro-Fernández M, Bory F,
Barenys M, Bujanda L, Lisozain J, Calvo MM, Torra S, Gisbert JP, Calvet X.
Aliment Pharmacol Ther
. 2012 Sep;36(5):414-25.
Meta-analysis: esomeprazole or
rabeprazole vs. first-generation pump inhibitors in the treatment of Helicobacter pylori
infection
. McNicholl AG, Linares PM, Nyssen OP, Calvet X, Gisbert JP.